logo
Plus   Neg
Share
Email

Medtronic Updates Fiscal 2019 Revenue Growth, EPS Guidance - Quick Facts

Medtronic plc (MDT) announced, for fiscal 2019, the company increased implied constant currency non-GAAP EPS growth forecast to a range of 9 to 10 percent from a range of 8 to 9 percent. The company maintained non-GAAP EPS guidance in the range of $5.10 to $5.15.

For fiscal 2019, the company increased organic revenue growth guidance to a range of 4.5 to 5.0 percent from a range of 4.0 to 4.5 percent. If recent exchange rates hold for the remainder of the fiscal year, fiscal 2019 revenue would be negatively affected by approximately $420 million to $520 million.

For the first-quarter, non-GAAP net income and diluted EPS were $1.601 billion and $1.17, respectively, both increases of 4 percent. Adjusting for the divestiture and a positive 5 cent impact from foreign currency, first quarter non-GAAP EPS increased 9 percent.

first quarter worldwide revenue was $7.384 billion, a decrease of 0.1 percent as reported, or an increase of 6.8 percent on an organic basis.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. is taking necessary precautions including Covid-19 testing for those employees returning to work at its headquarters in Silicon Valley, Bloomberg reported citing people familiar with the process. The company, which opened its main Apple Park office in May bringing back some hardware and software engineers, plans the gradual reopening of the building keeping the coronavirus safeguards. A U.S. appeals court has blocked the sales of Bayer AG's dicamba-based Xtendimax in the United States. The three-judge panel in the U.S. Court of Appeals for the Ninth Circuit ruled that the US Environmental Protection Agency (EPA) overstated the protections and substantially understated or ignored the risks related to the use of dicamba-based herbicides. Tesla Chief Executive Officer Elon Musk has called for a breakup of Amazon after the online retail giant refused to publish an upcoming book about COVID-19. Writer Alex Berenson said on Twitter that Amazon refused to publish his booklet about the coronavirus as it did not comply with the company's guidelines. Berenson is a former New York Times reporter.
Follow RTT